Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LUNG CANCER, SUSCEPTIBILITY TO
|
3 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.700 | 0 | ||||||||
Breast Carcinoma
|
2793 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.020 | 1.000 | 2 | 2010 | 2012 | |||||
Malignant neoplasm of breast
|
3417 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Malignant Neoplasms
|
1641 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Primary malignant neoplasm
|
1374 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Rheumatoid Arthritis
|
2387 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||
Acute Promyelocytic Leukemia
|
21 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Autoimmune thyroiditis
|
76 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
cervical cancer
|
268 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1 | 2017 | 2017 | ||||||
Cervix carcinoma
|
283 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1 | 2017 | 2017 | ||||||
Colorectal Carcinoma
|
1962 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Degenerative polyarthritis
|
247 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Esophageal carcinoma
|
272 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Gallbladder Carcinoma
|
75 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Hashimoto Disease
|
131 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Intervertebral Disc Degeneration
|
47 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of gallbladder
|
81 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Malignant tumor of cervix
|
245 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1 | 2017 | 2017 | ||||||
Multiple tumors
|
12 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Nodular Goiter
|
12 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.649 | 0.280 | 10 | 88989499 | intron variant | G/A;T | snv | 0.15 | 0.010 | 1.000 | 1 | 2014 | 2014 |